Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Mick McGuire, Marcato Reiterate 6.7% Stake in Sotheby’s, Issues Presentation

McGuire, Marcato: In a new filing with the SEC, Marcato Capital Management, a hedge fund managed by Richard McGuire, disclosed its presentation during the “Excellence in Investing: San Francisco” conference held yesterday. In the presentation, Marcato presented its case on Sotheby’s (NYSE:BID), and expressed its ideas regarding the company’s value. The key points Marcato made were that Sotheby’s owned real estate and financing operations are strengths that investors may be overlooking. Marcato holds around 4.6 million shares of Sotheby’s, which represent about 6.7% of the company.

Mick McGuire

Marcato also suggests that Sotheby’s has a lot of excess capital that it can re-invest in itself for the highest return opportunities, and if such opportunities cannot be found, the capital should be returned to shareholders. Also Marcato stated that the auction house has $1.3 billion worth of trapped equity value, which represents around $19 per share. In this way, the company should initiate a $1.3 billion share buyback that would bring more long-term value.

At the beginning of October, Dan Loeb’s Third Point reported raising its stake in Sotheby’s to 9.3%, which made it the largest shareholder of the company. In a letter sent by Third Point to William F. Ruprecht, the Sotheby’s CEO, the hedge fund showed concern about the direction and leadership of the company, as well as its disadvantages in comparison to another big auction house, Christie’s.

Disclosure: none

Recommended Reading:

Carl Icahn Ups Apple Stake to Nearly $2.5B, Full Letter to Tim Cook Here

Samuel Isaly’s Orbimed Advisors Sells Some Intercept Pharmaceuticals Stock at $62.50/Share

Par Capital Management Ups Majority Stake in Global Eagle Entertainment

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!